Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Jul 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.7M
Net Open-Market Flow
-$2.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Gift(G)75K—$0921K
Jul 8, 2026Sell(S)20K$133.63$2.7M996K

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-082758) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML